Type of publication:
Journal article
Author(s):
Crowley, L E; *Mekki, M; *Chand, S 
Citation:
Molecular Diagnosis and Therapy; Oct 2018; vol. 22 (no. 5); p. 537-550
Abstract:
This review is focused on present and future biomarkers, along with pharmacogenomics used in clinical practice for kidney transplantation. It aims to highlight biomarkers that could potentially be used to improve kidney transplant early and long-term graft survival, but also potentially patient co-morbidity. Future directions for improving outcomes are discussed, which include immune tolerance and personalising immunosuppression regimens.
